1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
ScienceGlobal issues

Can a new drug benefit Alzheimer’s treatment?

October 5, 2023

In May 2023 a US pharmaceuticals company published the provisional findings from a study on its Alzheimer antibody 'Donanemab'. 47 percent of patients treated with the new compound remained stable.

https://p.dw.com/p/4WyvW